GSK announces commencement of tender offer to acquire Nuvalent, Inc.
GSK plc (LSE/NYSE: GSK) today announced that Harmony Row Acquisition Co. (“Purchaser”), a direct wholly-owned subsidiary of GlaxoSmithKline LLC (“GSK LLC”), which is an indirect wholly-owned subsidiary of GSK, has commenced a tender offer to purchase …